← Oncology Approval Tracker

FDA DECISION ·

Imfinzi

durvalumab · AstraZeneca

FDA approvalNew or expanded indicationMuscle-invasive bladder cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

For adults with muscle-invasive bladder cancer, with gemcitabine and cisplatin before surgery and then as durvalumab alone after radical cystectomy.

LAMPGEN ANALYSIS

Why it matters

NIAGARA established a perioperative immunotherapy and chemotherapy option for patients planned for cystectomy.

What research teams should watch

Align cisplatin eligibility, preoperative dosing, and post-surgical recovery assessments across medical oncology and urology.

PRIMARY RECORDS

Sources